Ascendis Pharma A (ASND) EBITDA Margin Growth (1y) (2015 - 2026)
Ascendis Pharma A (ASND) EBITDA Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1,049.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,238.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.76 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -1,651.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,002.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,091.00 |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | 11,329.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,329.00 |
| Dec 31, 2025 | -12.36 Mn |
| Sep 30, 2025 | 17,243.00 |
| Jun 30, 2025 | 33,668.00 |
| Mar 31, 2025 | -5,198.00 |
| Dec 31, 2024 | 12.36 Mn |
| Sep 30, 2024 | 11,254.00 |
| Jun 30, 2024 | -7,301.00 |
| Mar 31, 2024 | 37,652.00 |
| Dec 31, 2023 | 63,166.00 |
| Sep 30, 2023 | 66,528.00 |
| Jun 30, 2023 | 200,629.00 |
| Mar 31, 2023 | 144,728.00 |
| Dec 31, 2022 | -51,304.00 |
| Sep 30, 2022 | 776,398.00 |
| Jun 30, 2022 | 920,623.00 |
| Mar 31, 2022 | 1.48 Mn |
| Dec 31, 2021 | 768.00 |
| Sep 30, 2021 | -584,999.00 |
| Jun 30, 2021 | -573,343.00 |